Entera Bio (ENTX) Short Interest Ratio & Short Volume $1.84 -0.06 (-3.16%) As of 03:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Entera Bio Short Interest DataEntera Bio (ENTX) has a short interest of 47,700 shares. This marks a 31.04% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 96,404 shares to cover all short positions.Current Short Interest47,700 sharesPrevious Short Interest36,400 sharesChange Vs. Previous Month+31.04%Dollar Volume Sold Short$87.29 thousandShort Interest Ratio0.4 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares45,660,000 sharesPercentage of Shares Shorted0.10%Today's Trading Volume46,830 sharesAverage Trading Volume96,404 sharesToday's Volume Vs. Average49% Short Selling Entera Bio? Sign up to receive the latest short interest report for Entera Bio and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENTX Short Interest Over TimeENTX Days to Cover Over TimeENTX Percentage of Float Shorted Over Time Entera Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202547,700 shares $87.29 thousand +31.0%N/A0.4 $1.83 8/31/202536,400 shares $70.25 thousand -2.2%0.1%0.3 $1.93 8/15/202537,200 shares $74.40 thousand -33.0%N/A0.3 $2.00 7/31/202555,500 shares $107.12 thousand +48.4%0.1%0.5 $1.93 7/15/202537,400 shares $70.31 thousand -32.4%N/A0.9 $1.88 6/30/202555,300 shares $105.07 thousand -22.9%0.1%1.4 $1.90 6/15/202571,700 shares $133.36 thousand -9.5%0.2%1.8 $1.86 5/31/202579,200 shares $145.33 thousand +57.5%0.2%1.9 $1.84 5/15/202550,300 shares $100.85 thousand -64.2%0.2%1.1 $2.01 4/30/2025140,500 shares $304.89 thousand +92.2%N/A2.7 $2.17 Get the Latest News and Ratings for ENTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. 4/15/202573,100 shares $132.31 thousand -2.3%0.2%1.3 $1.81 3/31/202574,800 shares $127.16 thousand -13.1%0.2%1.1 $1.70 3/15/202586,100 shares $161.87 thousand -13.7%0.3%0.8 $1.88 2/28/202599,800 shares $184.63 thousand -4.5%0.3%0.8 $1.85 2/15/2025104,500 shares $253.94 thousand +59.5%0.3%0.9 $2.43 1/31/202565,500 shares $143.45 thousand -31.6%N/A0.5 $2.19 1/15/202595,800 shares $218.42 thousand +102.5%N/A0.7 $2.28 12/31/202447,300 shares $100.28 thousand -23.1%N/A0.4 $2.12 12/15/202461,500 shares $132.84 thousand -2.4%N/A0.9 $2.16 11/30/202463,000 shares $103.32 thousand +19.8%N/A0.9 $1.64 11/15/202452,600 shares $91.00 thousand +19.0%N/A0.8 $1.73 10/31/202444,200 shares $80.00 thousand +9.4%N/A1.4 $1.81 10/15/202440,400 shares $73.12 thousand -14.4%N/A1.1 $1.81 9/30/202447,200 shares $89.68 thousand +38.4%N/A1.2 $1.90 9/15/202434,100 shares $67.86 thousand +27.7%N/A0.7 $1.99 8/31/202426,700 shares $44.59 thousand -4.0%N/A0.5 $1.67 8/15/202427,800 shares $44.48 thousand +11.7%N/A0.5 $1.60 7/31/202424,900 shares $40.09 thousand -51.0%N/A0.3 $1.61 7/15/202450,800 shares $95.00 thousand -29.4%N/A0.5 $1.87 6/30/202471,900 shares $132.30 thousand -7.2%N/A0.4 $1.84 6/15/202477,500 shares $160.43 thousand -15.2%N/A0.4 $2.07 5/31/202491,400 shares $205.65 thousand -28.0%N/A0.4 $2.25 5/15/2024127,000 shares $332.74 thousand +260.8%N/A0.5 $2.62 4/30/202435,200 shares $68.99 thousand -60.9%N/A0.1 $1.96 4/15/202489,900 shares $226.55 thousand +1.9%N/A0.4 $2.52 3/31/202488,200 shares $147.29 thousand +988.9%N/A0.5 $1.67 3/15/20248,100 shares $11.10 thousand +523.1%N/A0.1 $1.37 2/29/20241,300 shares $1.79 thousand -95.0%N/A0 $1.38 2/15/202426,100 shares $27.41 thousand +715.6%N/A0.3 $1.05 1/31/20243,200 shares $2.66 thousand -80.5%N/A0 $0.83 1/15/202416,400 shares $17.88 thousand -73.9%0.1%0.2 $1.09 12/31/202362,800 shares $37.68 thousand +5.7%0.3%1.2 $0.60 12/15/202359,400 shares $39.06 thousand -13.0%0.3%1.7 $0.66 11/30/202368,300 shares $47.92 thousand -3.1%0.3%2.1 $0.70 11/15/202370,500 shares $50.49 thousand +29.6%0.3%2.1 $0.72 10/31/202354,400 shares $37.30 thousand +8.8%0.3%1.3 $0.69 10/15/202350,000 shares $36.50 thousand -16.0%0.2%1.2 $0.73 9/30/202359,500 shares $43.14 thousand +18.3%0.3%1.5 $0.73 9/15/202350,300 shares $34.46 thousand +89.1%0.2%1.3 $0.69 8/31/202326,600 shares $17.82 thousand +24.9%0.1%0.8 $0.67 8/15/202321,300 shares $12.78 thousand -42.7%0.1%0.6 $0.60 7/31/202337,200 shares $29.39 thousand +268.3%0.2%1.3 $0.79 7/15/202310,100 shares $8.56 thousand -55.5%0.1%0.3 $0.85 6/30/202322,700 shares $19.15 thousand +291.4%0.1%0.7 $0.84 6/15/20235,800 shares $4.87 thousand -82.3%0.0%0.1 $0.84 5/31/202332,800 shares $26.01 thousand -12.8%0.2%0.5 $0.79 5/15/202337,600 shares $38.04 thousand -23.7%0.2%0.2 $1.01 4/30/202349,300 shares $37.96 thousand -54.5%0.2%0.2 $0.77 4/15/2023108,400 shares $92.63 thousand -52.5%0.5%0.5 $0.85 3/31/2023228,200 shares $264.71 thousand +22.8%1.0%1 $1.16 3/15/2023185,900 shares $187.76 thousand +114.4%0.8%0.8 $1.01 2/28/202386,700 shares $77.68 thousand +181.5%0.4%0.4 $0.90 2/15/202330,800 shares $29.06 thousand -3.5%0.1%0.5 $0.94 1/31/202331,900 shares $29.28 thousand -0.6%0.1%0.3 $0.92 1/15/202332,100 shares $26.64 thousand -47.5%N/A0.3 $0.83 12/30/202261,100 shares $44.60 thousand +8.5%N/A0.5 $0.73 12/15/202256,300 shares $35.29 thousand -8.5%N/A0.5 $0.63 11/30/202261,500 shares $41.75 thousand -43.4%N/A0.5 $0.68 11/15/2022108,700 shares $58.46 thousand -26.6%N/A0.9 $0.54 10/31/2022148,100 shares $115.90 thousand +119.7%N/A1.9 $0.78 10/15/202267,400 shares $56.62 thousand +160.2%N/A1 $0.84 9/30/202225,900 shares $26.94 thousand -54.8%N/A0.4 $1.04 9/15/202257,300 shares $76.21 thousand +38.7%N/A1.7 $1.33 8/31/202241,300 shares $55.76 thousand -5.9%N/A1.1 $1.35 8/15/202243,900 shares $77.70 thousand -48.5%N/A1.4 $1.77 7/31/202285,300 shares $165.48 thousand +9.1%N/A2.5 $1.94 7/15/202278,200 shares $109.48 thousand -11.4%N/A2.4 $1.40 6/30/202288,300 shares $117.44 thousand -30.3%N/A2.6 $1.33 6/15/2022126,700 shares $219.19 thousand -14.7%N/A3.4 $1.73 5/31/2022148,600 shares $319.49 thousand +4.2%N/A4.2 $2.15 5/15/2022142,600 shares $306.59 thousand -1.7%N/A3.9 $2.15 4/30/2022145,000 shares $355.25 thousand +10.1%N/A3.6 $2.45 4/15/2022131,700 shares $345.05 thousand -24.7%N/A2.5 $2.62 3/31/2022174,800 shares $501.68 thousand -13.1%N/A2.9 $2.87 3/15/2022201,200 shares $440.63 thousand -2.5%N/A1.9 $2.19 2/28/2022206,400 shares $439.63 thousand +12.7%N/A1.9 $2.13 2/15/2022183,200 shares $395.71 thousand -31.6%N/A1.6 $2.16 1/31/2022267,800 shares $613.26 thousand -11.0%N/A2.2 $2.29 1/15/2022300,800 shares $851.26 thousand +7.4%N/A0 $2.83 12/31/2021280,000 shares $789.60 thousand +9.3%N/A2.4 $2.82 12/15/2021256,300 shares $797.09 thousand +5.4%N/A2.9 $3.11 11/30/2021243,100 shares $811.95 thousand -16.8%N/A2.6 $3.34 11/15/2021292,200 shares $1.10 million -8.3%N/A2.8 $3.78 10/29/2021318,500 shares $1.36 million -3.7%N/A2.6 $4.26 10/15/2021330,800 shares $1.50 million -11.4%N/A2.1 $4.52 9/30/2021373,200 shares $1.76 million +21.3%N/A1.8 $4.71 9/15/2021307,600 shares $1.41 million -25.4%N/A0.7 $4.59 8/31/2021412,300 shares $2.01 million +119.5%N/A0.1 $4.88 8/13/2021187,800 shares $1.01 million +57.4%1.0%0.1 $5.40 7/30/2021119,300 shares $613.20 thousand -33.3%0.6%0 $5.14 7/15/2021178,800 shares $935.12 thousand -74.4%1.1%0.1 $5.23 6/30/2021697,100 shares $4.17 million +903.0%4.2%0.2 $5.98 6/15/202169,500 shares $259.24 thousand -9.4%0.4%0 $3.73 5/28/202176,700 shares $247.74 thousand -15.1%0.5%0 $3.23 5/14/202190,300 shares $263.68 thousand -57.1%N/A0 $2.92 4/30/2021210,400 shares $715.36 thousand +115.6%N/A0 $3.40 4/15/202197,600 shares $321.10 thousand +21.1%N/A0 $3.29 3/31/202180,600 shares $265.98 thousand -94.8%N/A0 $3.30 3/15/20211,540,000 shares $10.63 million +1,036.5%N/A0.2 $6.90 2/26/2021135,500 shares $239.84 thousand -13.4%N/A0.2 $1.77 2/12/2021156,500 shares $284.83 thousand +17.6%N/A0.2 $1.82 1/29/2021133,100 shares $185.01 thousand -8.8%N/A0.2 $1.39 1/15/2021145,900 shares $180.92 thousand +256.7%N/A0.3 $1.24 12/31/202040,900 shares $44.99 thousand -17.4%0.4%0.1 $1.10 12/15/202049,500 shares $52.97 thousand +56.7%0.5%0.1 $1.07 11/30/202031,600 shares $33.50 thousand -41.2%0.3%0.3 $1.06 11/15/202053,700 shares $56.12 thousand +42.1%0.5%0.6 $1.05 10/30/202037,800 shares $41.58 thousand +7.4%0.4%0.3 $1.10 10/15/202035,200 shares $40.13 thousand -49.9%0.3%0.2 $1.14 ENTX Short Interest - Frequently Asked Questions What is Entera Bio's current short interest? Short interest is the volume of Entera Bio shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 47,700 shares of ENTX short. Learn More on Entera Bio's current short interest. Is Entera Bio's short interest increasing or decreasing? Entera Bio saw a increase in short interest in September. As of September 15th, there was short interest totaling 47,700 shares, an increase of 31.0% from the previous total of 36,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Entera Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Entera Bio: enGene Holdings Inc. (0.21%), Amarin Corporation PLC (1.96%), Alpha Teknova, Inc. (25.54%), Capricor Therapeutics, Inc. (26.57%), Replimune Group, Inc. (22.14%), Canopy Growth Corporation (6.97%), Alector, Inc. (7.66%), Mereo BioPharma Group plc - Sponsored ADR (6.94%), Upexi, Inc. (23.71%), Candel Therapeutics, Inc. (19.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Entera Bio stock? Short selling ENTX is an investing strategy that aims to generate trading profit from Entera Bio as its price is falling. ENTX shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Entera Bio? A short squeeze for Entera Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTX, which in turn drives the price of the stock up even further. How often is Entera Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTX, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies enGene Short Interest Data Amarin Short Interest Data Alpha Teknova Short Interest Data Capricor Therapeutics Short Interest Data Replimune Group Short Interest Data Canopy Growth Short Interest Data Alector Short Interest Data Mereo BioPharma Group Short Interest Data Upexi Short Interest Data Candel Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENTX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Dollar’s Crashing—What Are You Doing About It?The U.S. dollar is down 10.8%—its steepest drop since 1973. As global confidence in the dollar fades, centr...Lear Capital | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
